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Edited by Frances ShannonAbstract The interaction between pathogens and their multicel-
lular hosts is initiated by activation of pathogen recognition
receptors (PRRs). These receptors, that include most notably
members of the toll-like receptor (TLR) family, recognize spe-
ciﬁc pathogen-associated molecular patterns (PAMPs). TLR4
is a central part of the receptor complex that is involved in the
activation of the immune system by lipopolysaccharide (LPS)
through the speciﬁc recognition of its endotoxic moiety (Lipid
A). This is a critical event that is essential for the immune
response to Gram-negative bacteria as well as the etiology of
endotoxic shock. Interestingly, compared to mammals, ﬁsh are
resistant to endotoxic shock. This in vivo resistance concurs with
in vitro studies demonstrating signiﬁcantly lowered sensitivity of
ﬁsh leukocytes to LPS activation. Further, our in vitro analyses
demonstrate that in trout mononuclear phagocytes, LPS fails to
induce antiviral genes, an event that occurs downstream of TLR4
and is required for the development of endotoxic shock. Finally,
an in silico approach that includes mining of diﬀerent piscine
genomic and EST databases, reveals the presence in ﬁsh of all
of the major TLR signaling elements except for the molecules
speciﬁcally involved in TLR4-mediated endotoxin recognition
and signaling in mammals. Collectively, our analysis questions
the existence of TLR4-mediated cellular responses to LPS in
ﬁsh. We further speculate that other receptors, in particular
beta-2 integrins, may play a primary role in the activation of
piscine leukocytes by LPS.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pathogen recognition is one of the most basic and important
properties of the immune system. It is assumed that the need
for organisms to recognize pathogens and distinguish between
‘‘self’’ and ‘‘non-self’’ arose at the time of the appearance of
the ﬁrst metazoans [1]. This process relies on the existence of
speciﬁc, structurally conserved components that are produced*Corresponding author. Fax: +1 414 382 1705.
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isms. These components, which are absent in multicellular
hosts, are popularly referred to as pathogen-associated molec-
ular patterns (PAMPs). Typical PAMPs are lipopolysaccha-
rides (LPS) of Gram-negative bacteria, peptidoglycan and its
structural component muramyl dipeptide (MDP) of Gram-
positive bacteria, fungal beta-glucans, and double-stranded
RNA (dsRNA).
The initial recognition and biological response to PAMPs or
other exogenous or endogenous substances that signal danger
or directly compromise the homeostasis of an organism are
mediated by genotypically encoded pathogen recognition
receptors (PRRs). Structurally and functionally similar PRRs
are shared between vertebrates, invertebrates, and even plants.
For example, the toll-like receptors (TLRs) in vertebrates be-
long to a family that also includes the toll receptor in Drosoph-
ila [2] and, according to some authors, the R proteins in plants
[3,4].
TLRs have drawn a great deal of attention after the discov-
ery in the late 1990s that mammalian TLR4 is critically in-
volved in the etiology of LPS-induced septic shock [5–7].
LPS is widely used to experimentally induce potent immune
reactions in mammals. It is the major constituent of the exter-
nal layer of the outer membrane of Gram-negative bacteria.
LPS is composed of three distinct parts: a carbohydrate ‘‘O-
antigen’’ and oligosaccharide core region, and a lipid portion
termed ‘‘lipid A’’ that is responsible for the activation of the
innate immune response in mammals and confers the endo-
toxic properties of LPS [8,9].
With the isolation and characterization of additional TLRs
in mammals, it was determined that members of this receptor
family detect the presence of diverse PAMPs including, for
example, LPS, peptidoglycan, double-stranded RNA, ﬂagellin,
and tri/diacylated bacterial lipoproteins. Excitingly, it also
turned out that diﬀerent members of the TLR family can trans-
mit signals that activate distinct intracellular signaling cas-
cades that may eventually result in pathogen-speciﬁc cellular
responses [10,11].
Recently, there have been several studies on ﬁsh that have
identiﬁed many ﬁsh orthologs of mammalian TLRs [12–14].
In addition, it appears that some of these orthologs are func-
tionally analogous. For example, it was shown that TLR3 iso-
lated from zebraﬁsh (Danio rerio) is involved in the activation
of NFjB, whereas trout TLR5, like its mammalian counter-
part, activates the immune system upon detection of bacterialblished by Elsevier B.V. All rights reserved.
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diﬀerences in the recognition and the response to certain
PAMPs across vertebrates.
It has been known for a long time that lower vertebrates,
most notably ﬁsh and amphibians, are resistant to the toxic
eﬀects of LPS [16]. It is also remarkable that in many
in vitro studies on leukocytes from diﬀerent ﬁsh species, extre-
mely high (e.g., lg/ml) concentrations of LPS have been used
to induce immune responses [17–21] in comparison to studies
on mammals. This fact motivated us to analyze previously
published data which, together with new observations, allows
us to hypothesize that: The diﬀerences in the biological
response to LPS between ﬁsh and mammals are likely deter-
mined by diﬀerences in their receptor-mediated recognition
of LPS. Namely, it appears that the TLR4-associated
molecules (CD14, LY96 (MD-2) and TICAM2 (TRAM)) that
participate in the TLR4-mediated response to the endotoxic
moiety of LPS in mammals, may be absent or may perform
diﬀerent functions in ﬁsh. Our analysis also suggests that other
PRRs such as beta-2 integrins, a group of well-conserved an-
cient molecules, may play a primary role in the LPS recogni-
tion by the piscine immune system.2. TLR4-mediated endotoxin recognition in mammals
Besides being the ﬁrst to be identiﬁed [22], mammalian
TLR4 is by far the best functionally characterized member
of the TLR family. There are two features that set TLR4 apart
from other TLR family members. First, TLR4 mediates the
immune response to very low (picomolar) concentrations of
LPS through complex interactions with extracellular accessory
molecules (discussed in further detail below) and second, com-
pared to other TLRs, the magnitude of the TLR4-mediated
cellular response is much higher and more persistent. In addi-
tion, TLR4 activation by LPS leads to activation of a much
wider array of immune genes which include both proinﬂamma-
tory cytokines (e.g., TNF-a, IL-1b, IL-12, etc.) and genes spe-
ciﬁcally involved in the antiviral response, including type-1
interferons and interferon-inducible genes [11,23–25].
According to the current model, LPS aggregates are recog-
nized initially by the lipopolysaccharide binding protein
(LBP) which is an acute phase serum protein that is a member
of the lipid transfer – LT/LBP family [26,27]. In turn, LBP
facilitates the transfer of LPS to CD14 [28,29], which is fol-
lowed by relocation of monomeric LPS to TLR4-associated
LY96. LY96 speciﬁcally binds to the lipid A portion (the endo-
toxic moiety) of LPS [30] which results in homodimerization
and activation of TLR4 [31,32]. The activation of TLR4 is fol-
lowed by recruitment of intracellular adapter molecules
through interactions of their toll-interleukin-1 resistance
(TIR) domains. Initially, it was found that TLR4 associates
with MyD88, an adaptor molecule that contains both a TIR
and a death domain [33] and which is implicated in the signal-
ing of all mammalian TLRs studied so far except for TLR3
[34]. However, it was discovered later that the association be-
tween TLR4 and MyD88 is obligatorily mediated by TIRAP
(Mal) which is another member of the TIR domain-containing
adapter molecules [35–38]. In addition, more recent studies dis-
covered another adapter molecule, named toll-like receptor
adaptor molecule 1 (TICAM1, TRIF) which, similarly to
MyD88, indirectly associates with TLR4 through the toll-likereceptor adaptor molecule 2 (TICAM2). However, unlike
MyD88 which mediates the early activation of NFjB, the
TICAM1/2 activation is involved in both the TLR4-mediated
induction of antiviral genes and the late phase of NFjB activa-
tion [38–40]. In addition to TLR4, TICAM1 is also recruited
by TLR3 which is a receptor for dsRNA and the structural
homolog of dsRNA, poly(I:C) [41].
MyD88 activation leads to the subsequent activation of a
string of signal transduction factors most notably; IRAK4,
IRAK1, TRAF6, and IKBK, IKBKB, IKBKG (IKKa/b/c)
[42–44]. Ultimately, this signaling cascade leads to the degra-
dation of the inhibitor of NFjB (IjB) and release of NFjB
p50 and p65 subunits which then migrate into the cell nucleus
as heterodimers and drive the expression of proinﬂammatory
genes [45]. In contrast to MyD88, recruitment of TICAM1
downstream of TLR4 and TLR3 is followed by activation of
the NAP1/IKBKE/TBK kinase complex and subsequently
IRF-3 that eventually drives the expression of type I interfer-
ons. However, TICAM1 can also activate NFjB through
RIP1 and, successively, TRAF6 and its downstream targets
[34].
So far, it appears that TLR4 is the only member of the TLR
family that is able to recruit and activate two diﬀerent pairs of
TIR domain-containing adaptor molecules (TIRAP/MyD88
and TICAM1/2). This distinct ability, apparently determines
its potent and often extremely adverse biological eﬀects [23].
This was clearly demonstrated through the ﬁnding that induc-
tion of type I interferons by LPS is essential for the etiology of
endotoxic shock [46].3. Response of rainbow trout mononuclear phagocytes to LPS
In an in vitro study, part of which was published recently
[47], we analyzed the dose–response of trout mononuclear
phagocytes (rtMOCs) after stimulation with diﬀerent PAMPs
including zymosan (yeast cell wall extract), muramyl dipeptide
(MDP, structural component of peptidoglycan), particulate
and soluble b-glucan from yeast, poly(I:C) (dsRNA analog)
and 5 diﬀerent LPS preparations. Interestingly, after stimula-
tion with zymosan, MDP, particulate b-glucan and poly(I:C),
the cells responded by the upregulation of proinﬂammatory
cytokines with the same sensitivity as observed with mamma-
lian cells (Fig. 1; data showing the dose response to particulate
b-glucan and poly(I:C) are not shown). On the other hand,
upregulation of TNF2 by rtMOCs required 1000-fold higher
LPS concentrations than those needed to induce a similar re-
sponse in mammalian cells (Fig. 1).
Another study suggested that ﬁsh, in particular rainbow
trout and cod, may lack an important component of the
LPS recognition receptor complex. Namely, it was recognized
that the LBP homologs that had been characterized in trout
and cod [48,49] were more likely functional analogs of the
mammalian bactericidal permeability increasing protein
(BPI) [49]. BPI is another member of the LT/LBP family that,
unlike LBP, transfers monomeric LPS to high density lipo-
proteins instead of CD14. This leads to the neutralization
of LPS and interferes with the activation of TLR4 [50–52].
Therefore, it was speculated that the absence of a LBP analog
may explain the attenuated sensitivity to LPS in ﬁshes [49].
The hypothesis that trout lack functional LBP was further
corroborated by our study that showed that the sensitivity
Fig. 1. Dose-dependent TNF2 induction by diﬀerent PAMPs. Diﬀerentiated rtMOCs, prepared as previously described [91], were stimulated for 12 h
at various PAMP concentrations in the presence of 10% fetal bovine serum (FBS). TNF2 expression in total RNA was analyzed using Northern blot
(upper 4 panels) and RT-PCR (lower 3 panels) as previously described [47]. Equal loading of RNA for Northern blotting was veriﬁed by staining
ribosomal RNA with ethidium bromide prior to transfer, while the quality of the cDNA used for RT-PCR was conﬁrmed by beta-actin ampliﬁcation
(data not shown). Northern data for the eﬀects of E. coli and P. aeruginosa phenol-extracted LPS, zymosan and MDP from Iliev et al. [47]. Ultra-
pure LPS from Invivogen and phenol-extracted V. anguillarum provided by Dr. J. Bogwald, University of Tromso (Tromso, Norway). The data
concerning the activation of mammalian macrophages was derived from the following papers: [92–94] for LPS, [95] for zymosan and [96,97] for
MDP.
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um [47].
Another interesting observation is that LPS-induced activa-
tion of rtMOCs cannot be inﬂuenced by the presence of poly-
myxin B (PMB) (Fig. 2). PMB is a cyclic cationic polypeptide
produced by Paenibacillus polymixa that binds to lipid A
[53,54] and thus interferes with the association between LPS
and LY96. In mammalian systems, PMB neutralizes the bio-
logical eﬀects of LPS and is widely used to eliminate the eﬀects
of endotoxin contamination, both in vitro and in vivo. There-
fore, our results with PMB and rtMOCs further suggest thatFig. 2. Polymyxin B does not prevent LPS activation of rtMOCs.
Diﬀerentiated rtMOCs were stimulated with varying concentrations of
E. coli LPS in the presence (+) or the absence () of polymyxin B
(Sigma). Panel A: Northern blot of TNF2 induction after stimulation
for 12 h in the presence of 10% FBS. Panel B: RT-PCR of TNF2
induction after 3 h of stimulation in the presence of 5% homologous
trout serum. Methods as described or referenced in Fig. 1.there might be substantial diﬀerences in the LPS detection
mechanisms between mammals and ﬁshes.
As discussed earlier, the TLR4-mediated response to LPS
involves upregulation of antiviral genes through a TICAM2–
TICAM1–IRF-3-dependent pathway [39]. These genes include
type-1 interferons and interferon-inducible genes which are in-
duced secondarily through a STAT1-dependent pathway
downstream of the interferon-a/b receptor [24]. We analyzed
the induction of proinﬂammatory genes (TNF2 and cyclooxy-
genase-2, COX-2) and homologs of mammalian antiviral genes
(interferon-alpha and IP-10-like protein). Crude, phenol-
extracted LPS (Sigma) was much more potent in inducing
the expression of proinﬂammatory genes compared to
poly(I:C), whereas the reverse was evident for the antiviral
genes (Fig. 3). In fact, ultra-pure LPS (Invivogen) did not ap-
pear to have activated antiviral genes at all. This suggests that
the activation of the genes involved in the antiviral response by
phenol-extracted LPS may have been driven by contaminants
in the preparation such as bacterial CpG DNA which can acti-
vate the expression of type-1 interferons through a TLR8-
IRF5/7-dependent pathway [55]. In addition, the ultra-pure
LPS preparation did not induce IFN-a and IP-10-like protein
in rtMOCs when the cells were stimulated in the presence of
homologous trout serum (data not shown). Further, a very re-
cent study presented similar data conﬁrming that in rainbow
trout head kidney leukocytes, IFN-a expression was inducible
by poly(I:C) and R848 (a TLR7/8 agonist) but not by LPS
preparations from Escherichia coli and Salmonella minnesota
[56]. In mammals, it has been clearly shown that non-entero-
bacterial LPS, that signals through TLR2, does not induce
the expression of type-1 interferons and fails to activate
STAT1 [24,25]. This is linked to the fact that induction of anti-
viral genes downstream of TLR4 is TICAM2/TICAM1-depen-
dent [39].
Fig. 3. Diﬀerential gene induction by LPS from E. coli and poly(I:C). Diﬀerentiated rtMOCs were stimulated for varying times with 50 lg/ml of LPS
or poly(I:C). Non-stimulated cells (‘‘C’’) were left untreated for 24 h. Expression of IFN-a, IP-10-like, TNF2, COX-2 and beta-actin were analyzed in
total RNA using RT-PCR. Results from two experiments are presented. The ﬁrst experiment includes treatments with phenol-extracted LPS and
poly(I:C). The second includes treatments with ultra-pure LPS and poly(I:C). The bands across each row (i.e., under LPS and poly(I:C) stimulation)
were obtained from the same experiment and were visualized on the same gel. Therefore, they can be directly compared.
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lular responses to LPS in ﬁsh deviate from the model estab-
lished for mammals and that the diﬀerences point to the
absence of TLR4-dependent activation of piscine leukocytes
by LPS stimulated under in vitro conditions.4. TLR4 and TIR domain-containing adaptor molecules in lower
vertebrates
TICAM1, TIRAP and MyD88 are very well evolutionarily
conserved and easily identiﬁable in ﬁsh genomic and EST dat-
abases. According to our observations, TICAM2 is very well-
conserved within mammals and its presence as a single gene
exon greatly facilitates its identiﬁcation in genomic databases.
Even so, we have been unable to ﬁnd a TICAM2 homolog in
any of the ﬁsh genomic databases. When murine TICAM2 is
used as a search query, the best match in all of the non-mam-
malian genomic databases is TICAM1, while the second best
match is usually TIRAP. Fig. 4A shows the evolutionary rela-
tions between TICAM1 and TICAM2. It is obvious that, com-
pared to TICAM1s, TICAM2s are much more tightly
clustered most likely as a result of their restricted functions
and the stronger ‘‘conservative’’ selective pressure exerted on
them. On the other hand, the evolutionary distance between
TICAM1s, both within and between diﬀerent vertebrate clas-
ses, is much larger. This may be a result of the diverse func-
tions of TICAM1s (e.g., conveying signals downstream of
diﬀerent TLRs).
In addition to TICAM2, searching for TLR4 reveals that
this receptor may be absent in the genomes of puﬀerﬁsh, Taki-
fugu rubripes (fugu) and Tetraodon nigroviridis, though it is
present in zebraﬁsh [57]. Although TLR4 is present in somelower vertebrates, the data we have discussed so far raises
the question of how well the function of TLR4 is conserved
across vertebrates. Interestingly, the extracellular domain of
TLR4 shares greater sequence similarity with CD180
(RP105) than with any of the other TLRs (Fig. 4). CD180
was not included in a recently published phylogenetic analysis
of the evolution of vertebrate TLRs as it did not meet the def-
inition of a TLR used by Roach et al. [14]. Our phylogenetic
analysis reproduces the topology of the TLR phylogenetic tree
published by these authors and reveals that the TLR4 and
CD180 lineages cluster together and form a distinct evolution-
ary branch when compared with other TLRs. It also appears
that these two genes evolved from a common ancestor shortly
before the divergence between ﬁshes and tetrapods (Fig. 4B).
Like TLR4, CD180 cooperates with an accessory molecule,
LY86 (MD-1), which is a close homolog to LY96 [58,59].
However, although CD180/LY86 is also implicated in the acti-
vation of the immune system by LPS, it does not directly bind
endotoxin [60,61]. CD180 lacks an intracellular TIR domain
and mediates cellular responses to LPS indirectly through
interaction with other receptors, including TLR4 and TLR2
[62–65]. These facts raise the question of whether the common
ancestor of TLR4 and CD180 was directly involved in the re-
sponse to LPS or whether this function arose later, after the
divergence between TLR4 and CD180. Although it is diﬃcult
to ﬁnd a convincing answer to this question, a closer look at
the phylogeny of LY96 seems to support the second possibil-
ity. LY96 is a small molecule that is not well conserved evolu-
tionarily and is not present in any of the ﬁsh EST databases. In
addition, the LY96 gene appears to be interrupted by several
introns (our unpublished observations) which makes its in sil-
ico identiﬁcation very diﬃcult. As a result, we cannot deter-
mine from the genomic databases whether LY96 exists in
Fig. 4. Phylogenetic analyses. Panel A: TRIF and TRAM are closely related; multidimensional scaling (MDS) of the molecular distances between
the TIR domains of the TLR-adapter proteins. TICAM2 is only found in mammals, suggesting a recent divergence from TICAM1. The distance
between the gene families compared to the distances within the gene families is so great that it is possible that portraying this information as a
molecular tree could be misleading. MDS permits visualization of the proximity of TICAM1 and TICAM2 with respect to MYD88 and TIRAP.
Distances are computed with PROTDIST at alignment positions with at least 80% non-gap characters (i.e., only from the TIR domain) from
alignments by CLUSTALX. MDS is performed as described in [98]. Panel B: Molecular tree of the toll-like LRR multigene family; CD180, CD14
and TLRS5 belong to the same superfamily as the vertebrate TLRs. The LRR domains of TLR4 are more closely related to CD180 than they are to
any other TLR. The LRR domains of TLR5 are more closely related to TLRS5 than they are to any other TLR. This molecular tree is derived from a
CLUSTALX alignment, followed by PROTDIST and FITCH from the PHYLIP package. Distance is calculated only from the 600 alignment
positions with at least 80% non-gap characters (out of 855), up to the end of the CD180 alignment (i.e., not including the TIR domain of the TLRs).
A single TLR is used to represent TLR clades described in [14], with additional illustrative TLRs from the TLR4 and TLR5 clades. CD180 is
monophyletic, but TLRS5 is not. This diﬀerence in relationships suggests diﬀerences in mechanisms of evolution and selection pressures and thus
diﬀerences in functional relationships. Mammals do not possess TLR5S. Xt: Xenopus tropicalis – frog; Gg: Gallus gallus – chicken; Hs:Homo sapiens;
Dr: Danio rerio – zebraﬁsh; Md: Monodelphis domestica – opossum; Mm: Mus musculus – mouse; Cf: Canis familiaris – dog; Om: Oncorhynchus
mykiss – trout; Tr: Takifugu rubripes – Torafugu puﬀerﬁsh; Tn: Tetraodon nigroviridis – spotted green puﬀerﬁsh.
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present in chicken. Interestingly, alignment (our unpublished
observations) of chicken LY96 and both LY96 and LY86 from
human and mouse shows that, like mammalian LY86, the
chicken LY96 homolog lacks the amino acids that are abso-
lutely required for the LPS-binding ability of mammalian
LY96 [60]. Moreover, chicken leukocytes, just like ﬁsh leuko-
cytes, require stimulation with much higher concentrations of
LPS to initiate a respiratory burst response [66]. Furthermore,
although E. coli LPS is pyrogenic for chickens, excessive doses
of LPS did not appear to be lethal for them, in sharp contrast
to the diﬀerent mammalian species studied by Berczi et al. [16].
Therefore, while TLR4 may be involved in the response to
LPS in non-mammalian vertebrates, the function of the
TLR4 receptor complex that mediates the ultra-sensitive and
exceptionally robust cellular reactions to endotoxin appears
to be restricted to mammals.
It may be argued that the piscine EST databases are still rel-
atively shallow. Currently, the number of ESTs from zebraﬁsh,
trout and salmon taken together is 10 times lower than the
number of EST sequences present in the human and the mur-
ine EST databases. In addition, the sequences of the ﬁsh gen-
omes are still not completely assembled and contain numerous
gaps. Both of these caveats may obstruct the identiﬁcation of
mammalian orthologs in the ﬁsh databases and may account
for the inability to identify elements involved in the TLR4-
mediated signaling. However, so far all of the major proximalelements of the common TLR signaling pathways (including
MyD88, TIRAP, TICAM1, IRAK-4 and TRAF6) have been
identiﬁed in the genomes and/or ESTs of diﬀerent ﬁsh species.
Therefore, it is quite remarkable that there are no identiﬁable
piscine homologs of all the genes (namely, CD14, LY-96 and
TICAM2) that are speciﬁcally involved in the TLR4-mediated
immune response.
A second possibility that may account for the failure to de-
tect these genes in ﬁsh may be the increased rate of their evo-
lution. There are genes (e.g., many cytokines) that evolve
rapidly resulting in the generation of highly divergent ortho-
logs that may be diﬃcult to identify through direct sequence
comparison. However, CD14, LY96 and TICAM2 appear to
be relatively well conserved within mammals. In fact, the sim-
ilarity between human and murine TICAM2 is higher than the
similarity between human and murine TICAM1 (Fig. 4A).
Therefore, if we assume that TICAM2, LY96 and CD14
orthologs already existed in the common predecessor of ﬁsh
and tetrapods, than it would mean that the selective pressure
on those genes, unlike the other proximal TLR signaling ele-
ments, diﬀered drastically throughout vertebrate evolution.
The increased rate of evolution of CD14, LY96 and TICAM2
during the evolution of tetrapods, particularly mammals, may
be explained by the adoption of novel functions that may have
redirected the selective pressure on those genes. Further, the
‘‘conservative’’ selective pressure on TICAM2, LY96 and
CD14 within mammals may have been governed by the need
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been TLR4-mediated endotoxin recognition and sensitivity
to LPS. For example, CD14 which appears to originate from
a TLR, possibly a member of the TLR2/14 clade, is relatively
poorly conserved between the vertebrate classes as compared
to TLRs (Fig. 4B).
A signiﬁcant part of the in vivo and the in vitro data that
supports our hypothesis is derived from studies on rainbow
trout for which there is no genomic data available. On the
other hand, the major part of our in silico analysis is based
on the genomes of ﬁsh (zebraﬁsh, fugu and Tetraodon) for
which experimental data concerning the immune response to
LPS is scant. Currently, there are no published data that would
suggest that zebraﬁsh and fugu are as sensitive to LPS as mam-
mals. In fact, papers that have reported on the in vitro stimu-
lation of peripheral blood leukocytes from fugu and isolated
kidneys from zebraﬁsh have used fairly high concentrations
of LPS (50 and 10 lg/ml, respectively) [67,68]. In addition, it
is interesting that IL-12 p35, a gene whose induction in murine
macrophages by LPS is strictly TLR4-dependent [69], was not
activated in fugu after intraperitoneal injections with LPS
though TNF and IL-1b were [70]. Furthermore, extremely
high concentrations of LPS (500 lg/ml) have been used to
stimulate peripheral blood leukocytes from Paralichthys oliva-
ceus [71,72], a relative of Fugu and Tetraodon (Series Perco-
morpha). Finally, zebraﬁsh belong to the family Cyprinidae
and carp, another member of this family, were used in the
LPS sensitivity experiments that demonstrated resistance of
this species to endotoxic shock [16]. It seems unlikely that so
closely related species may exhibit fundamental diﬀerences in
their response to LPS.5. Alternative receptors for LPS
In addition to the TLR4 complex, enterobacterial LPS has
been shown to interact with several other membrane-boundFig. 5. A schematic representation of the model of the CD14/LY96/TLR4
observations that question the presence of this model in ﬁsh. The TLR4 homproteins, including CD11/CD18 heterodimers (also known as
beta2 integrins), heat shock protein 70 (HSP70), HSP90, the
chemokine receptor CXCR4 and growth diﬀerentiation factor
5 (GDF5) [73,74]. In addition, many non-enterobacterial spe-
cies produce LPS that signal through TLR2 [11,75–79]. Re-
cently, Roach et al. [14] suggested that Fugu TLR23 may
participate in LPS recognition which may compensate for
the loss of TLR4 in this species. Also, based on the observation
that LPS from E. coli and Pseudomonas aeruginosa induced re-
sponses of diﬀerent durations in rtMOCs, we speculated previ-
ously that diﬀerent receptors might be involved in the
activation of rtMOCs by E. coli and P. aeruginosa LPSs [47].
Beta-2 integrins, which are one of the most abundant recep-
tor types found on macrophages, are especially remarkable be-
cause of their ability to transmit intracellular activation signals
through MAP kinases and NFjB [80–83]. In addition, these
PRRs are involved in the internalization of LPS and whole
bacteria [84]. It appears that, upon encountering bacteria,
beta-2 integrins recognize the hydrophilic carbohydrate moie-
ties of LPS which are exposed to the environment [85], but not
the hydrophobic endotoxic moiety that is buried in the outer
bacterial membrane. When LPS is released in aqueous solu-
tions it forms supra-molecular aggregates. The size of these
structures, which can assume micellar or lamellar shapes, cor-
relates with the LPS concentration and the availability of diva-
lent cations (e.g., Ca2+ and Mg2+) [86–88]. The LPS aggregates
apparently resemble the surface of Gram-negative bacteria and
perhaps it is these aggregates, rather than the endotoxic moiety
of LPS, that trigger the beta-2 integrin-mediated cellular re-
sponse. In support of this, the LPS concentrations required
for beta-2 integrin-mediated activation of NFjB are relatively
high (e.g., lg/ml) and close to the critical micelle concentration
(concentration above which LPS micelles can be detected) that
has been reported by diﬀerent authors [88,89].
Interestingly, we found that the LPS concentrations required
to activate rtMOCs were similarly high (Fig. 1). In addition,
we observed that the immunostimulatory potency of a given-dependent response to LPS. The right panel summarizes on the key
odimerization is not depicted for schematic clarity. See text for details.
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perse in water. For example, a highly dispersible, ultra-pure
LPS preparation (E. coli 0111:B4) weakly induced TNF2
expression in rtMOCs even when administered at high concen-
trations (Fig. 1). On the other hand, an ultra-pure LPS prepa-
ration (E. Coli K12 msbB mutant), that was diﬃcult to disperse
in water and formed a hazy stock solution (most likely because
of the presence of large LPS aggregates), activated rtMOCs at
much lower concentrations. We were also able to observe this
correlation with other LPS preparations that we tested on
rtMOCs. These observations suggest that the activation of
rtMOCs by LPS depends on the presence of supra-molecular
structures. Finally, the kinetics of activation of rtMOCs by
LPS are relatively delayed, taking hours to reach maximal
expression of inﬂammatory genes [47]. These features parallel
the characteristics of the beta-2 integrin-mediated activation
of mammalian cells which require stimulation with high con-
centrations of LPS to slowly activate NFjB [80]. Therefore,
our results suggest that beta-2 integrins may be key elements
in the recognition of LPS by trout macrophages. Nevertheless,
this does not exclude the possibility that other receptors,
including TLRs may be involved in the activation of rtMOCs
by LPS through collateral interactions with beta-2 integrins
and, subsequently, transmission of intracellular activation sig-
nals. A similar process has been observed in mammals [90].
In summary, our analysis questions the existence of CD14/
LY96/TLR4-mediated cellular responses to LPS in ﬁsh. While
TLR4 is present in non-mammalian vertebrates and might still
be involved in the immune response to LPS, its function ap-
pears to diﬀer signiﬁcantly between mammals and other verte-
brates. It is likely that the ability of TLR4 to initiate a robust
immune response upon exposure to minute amounts of endo-
toxin arose relatively late in the evolution of vertebrates, and
may be pertinent only to higher vertebrates. This seems to have
depended on the evolution of accessory (CD14 and LY96) and
adapter molecules (TICAM2) which, so far, have not been
found in ﬁsh. Our analysis also suggests that alternative signal-
ing receptors such as beta-2 integrins may play a primary role
in the activation of piscine leukocytes by LPS. The overall sup-
porting facts of our hypothesis are summarized in Fig. 5.6. Concluding remarks
Elimination of pathogens by the immune systems of their
multicellular hosts may occur directly through phagocytosis
which is mediated by receptors, such as integrins and scavenger
receptors. Alternatively, potentially pathogenic microorgan-
isms or their PAMPs may activate signaling receptors such
as TLRs that can consecutively initiate cellular and humoral
immune responses leading to indirect clearance of pathogens.
Unlike direct pathogen elimination, the TLR-mediated im-
mune reaction does not require the presence of the whole path-
ogen and can potentially initiate the immune reaction without
an immediate rendezvous between the pathogen and the host
leukocytes. This ‘‘reconnaissance’’ mechanism can add more
ﬂexibility to the immune reaction and can also provide the host
immunity with additional tactics to cope with an infection.
However, in mammals, erroneous reconnaissance input, such
as the uncontrolled activation of the TLR4 complex by exces-
sive amounts of LPS, may lead to an endotoxic reaction that is
devastating for the host. The intimate mechanisms of this pro-cess are relatively well understood; nevertheless, it is still un-
known whether the endotoxicity is merely a side-eﬀect that
accompanies the immune reaction to Gram-negative bacteria
or whether it provides any advantage for the species that exhi-
bit it. Therefore, more detailed studies on non-mammalian ver-
tebrates that do not manifest this phenomenon can be of
critical importance for its adequate understanding.
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